Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
16/11/2020
An interim review of trial data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults.
An interim review of trial data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults.